[29]Xu S，Li S，Guo Z，et al.Combined targeting of mTOR and AKT is an effective strategy for basal-like breast cancer in patient-derived xenograft models[J].Mol Cancer Ther，2013，12(8)：1665-1675.

    [30]Tomioka N，Azuma M，Ikarashi M，et al.The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)[J].Breast Cancer ......